Dirk Thye
Equibles does not estimate personal net worth.
About Dirk Thye
Earlier roles on record: CEO and Board Member at IRulya Therapeutics Inc. (IRLA) until September 29, 2026 and CEO and Board Member at IRulya Therapeutics Inc. (IRLA) until July 31, 2026. IRulya Therapeutics Inc. reported in an 8-K filed October 9, 2026 that Dirk Thye resigned as member of the Company’s Board of Directors. IRulya Therapeutics Inc. reported in an 8-K filed October 9, 2026 that Dirk Thye resigned as Chief Executive Officer and Chief Medical Officer. IRulya Therapeutics Inc. reported in an 8-K filed October 9, 2026 that Dirk Thye resigned as director, effective October 8, 2026. Equibles holds 6 filed executive changes naming Dirk Thye; each is listed under recent activity with its source filing. The proxy statement of IRulya Therapeutics Inc. reports total compensation of $2,493,625 for Dirk Thye in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 4 fiscal years.
“Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince, and a member of the Company’s Board of Directors, and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, have resigned.”
“Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince, and a member of the Company’s Board of Directors, and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, have resigned.”
Affiliation history
-
2022-01-01–2026-09-29
-
2022-01-01–2026-07-31
-
Start not stated–2026-09-29
-
Start not stated–2026-07-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | IRulya Therapeutics Inc. (IRLA) | Chief Executive Officer and Chief Medical Officer | $550,000 | $2,493,625 |
| 2024 | IRulya Therapeutics Inc. (IRLA) | Chief Executive Officer and Chief Medical Officer | $550,000 | $2,732,125 |
| 2023 | IRulya Therapeutics Inc. (IRLA) | Chief Executive Officer and Chief Medical Officer | $550,000 | $1,330,500 |
| 2022 | IRulya Therapeutics Inc. (IRLA) | Chief Executive Officer and Chief Medical Officer | $316,955 | $4,968,477 |